Statement Of Changes In Equity [Abstract]

GenSight Biologics S.A. - Filing #5982864

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through appropriation of retained earnings, equity
0 EUR
26 220 EUR
26 220 EUR
0 EUR
27,625,000 EUR
27,625,000 EUR
Increase (decrease) through conversion of convertible instruments, equity
242,000 EUR
3 158 EUR
2 916 EUR
60,000 EUR
60,000 EUR
Purchase of treasury shares
27,000 EUR
27,000 EUR
99,000 EUR
99,000 EUR
Share issue related cost
1 816 EUR
1 816 EUR
703,000 EUR
703,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.